New clinical-trial data on management of low-grade #glioma in Journal of Clinical Oncology: #Temozolomide Vs #Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU) ascopubs.org/doi/10.1200/... #EANOessentials

𝗠𝗲𝗻𝗶𝗻𝗴𝗶𝗼𝗺𝗮 𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝟮𝟬𝟮𝟲 – just two days left to benefit from the early registration rate! Join us in Rome on 28 September 2026, immediately following #EANO2026, for a dedicated day exploring the latest advances in meningioma research and clinical care. Register by 12 August 2026. #Meningioma #Rome

#EANO is inviting applications to host the EANO Seminar 2028 – an educational event dedicated to advances in CNS tumor pathogenesis and management for junior professionals across Europe. 📅 Apply by October 15, 2026 to office@eano.eu. 👉 www.eano.eu/eanomeetings... #EANO #EANOseminars2028 #CNS

Have you registered for #EANO2026 yet? Join the global #NeuroOncology community in Rome, Italy, from September 24–27, 2026. The #EANO Board is looking forward to welcoming you for four days of outstanding science, collaboration, and networking. 🎟 Register at the regular rate until August 12.

🎗️Today is Glioblastoma Awareness Day 2026 - a day to raise awareness of #glioblastoma. At EANO, we are constantly committed to advancing research, improving diagnosis, fostering international collaboration, and supporting the development of more effective treatments to improve outcomes for patients.

⏰ Regular Fees now available for #EANO2026 Missed the Early Bird? You can still secure your place at Europe’s leading #NeuroOncology congress. Join us in #Rome (IT), Sept 24–27, 2026, and connect with experts from around the world. 👉 eano.eu/eano2026/reg... 📅 Regular Fee period: July 8 – August 12

📢 The #EANO–EORTC CNS Metastasis Meeting 2027 marks a new chapter in #CNS metastasis research, bringing together researchers and clinicians to advance science and improve patient care. Abstract submission opens 31 Aug 2026. #CNSmetastasis2027 @eortc.org 👉 Learn more: www.eano.eu/eanomeetings...

🚨Just two days left! Early bird registration for #EANO2026 ends on July 7! Don't wait until fees go up to register. Learn more 👉https://eano.eu/eano2026/registration/ We are looking forward to meeting you in #Rome! #btsm #NeuroOncology #glioma #braintumor #neurosurgery

🧠 There's still time to register for the next #EANOYoungsters Journal Club! 📍 Opening Closed Doors 📅 14 July 2026 | 🕓 16:30 CEST 👉 Registration is free: zoom.us/webinar/regi... #Glioma #BrainTumor #EANOjournalclub

Promising advances in #glioma #immunotherapy – recently published in Nature Cancer: IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial; 👉 Read more: www.nature.com/articles/s43... #EANOessentials

🏆 Congratulations to EANO member Gaetano Gargiulo on receiving a prestigious ERC Advanced Grant! As Group Leader of the Molecular Oncology Lab at @mdc-berlin.bsky.social and an #EANO Scientific Committee member, he has secured €2.5M for the MOIRA project on pediatric brain tumors. 👏

🌏🤝A proud moment for EANO at #ASNO2026! #EANO President Michael Platten & ASNO President Rakesh Jalali signed an MoU to strengthen global collaboration in #NeuroOncology. Proud to begin this new chapter with ASNO & SNO, advancing the field together.@neuroonc.bsky.social @michael-platten.bsky.social

🌍 Discover the latest in #NeuroOncology at #EANO2026 From clinical trial results to breakthrough innovations – explore advances in basic science, precision diagnostics, and novel treatment approaches. Join us in #Rome (IT), Sept 24–27, 2026 and register today! 👉 eano.eu/eano2026/reg...

Recently published in Neuro-Oncology: BRAF-altered glioma in adults and children: A Society for Neuro-Oncology (SNO) and European Association for Neuro-Oncology (EANO) consensus review on clinical management and future directions Read more: doi.org/10.1093/neuo... #EANOessentials

🎗️ On #WorldBrainTumorDay 2026, "Advancing Brain Cancer Research" brought together the #NeuroOncology community, policymakers and patient advocates at the @europarl.europa.eu. #EANO representatives were proud to contribute to discussions on research and improving care for patients with #braintumors.

Each year on June 8th, #WorldBrainTumorDay is observed to raise awareness, educate people about brain tumors, and support those affected by it. #EANO is dedicated to foster advances in #NeuroOncology through innovative research, and concerted education & training. Together, we make a difference! 🎗️

👉 Insights into #radiotherapy – recently published in Radiotherapy and Oncology: Unexpected frequency of radiation induced contrast enhancement after proton radiotherapy in glioma patients treated within the Swedish PRO-CNS study Read more: lnkd.in/eZxX8cTi #EANOessentials #NeuroOncology #Glioma

👋 Students, Youngsters, Fellows, Postdocs, Nurses & AHP in #NeuroOncology! EANO invites you to register for the 21st Meeting of the European Association of Neuro-Oncology (#EANO2026) taking place from Sept 24-27, 2026 in Rome, IT. 👉 Register today! eano.eu/eano2026/reg... #btsm

‼️ Good news! Deadline for late-breaking abstract submission extended to June 09, 2026! Don't miss this opportunity to present your very latest reasearch breakthrough to the #NeuroOncology community at #EANO2026. Submit your abstract 👉 www.eano.eu/eano2025/abs... #btsm #braintumor

🚨 Tomorrow is the final day to submit your application for the #EANO2026Elections. If you have been thinking about taking on a role within #EANO, this is your last chance, applications close on 28 May 2026 at 23:59 (CEST). 👉 Apply via the EANO online application system on our website: www.eano.eu

🙌 What a year for European Association of Neuro-Oncology abstract submissions! This year, we reached a record-breaking 1,166 submitted abstracts. We are truly inspired by the dedication of the #EANOcommunity and their commitment to advancing #NeuroOncology. Thank you! #EANO2026 #braintumor #btsm

Are you a nurse or allied health professional contributing to #NeuroOncology research? This award recognises exceptional contributions in the field. Nominations are still open: 📅 Apply by May 15 📩 Submit nomination to: awards@eano.eu 👉 Learn more: www.eano.eu/eanomeetings... #btsm #nurse

🚀 Take an active role in #EANO! Applications are now open for the 2026–2028 elections – from the Executive Board to multiple committees. Bring in your expertise, represent your field, and help drive #NeuroOncology forward across Europe. 🗓 Apply by May 28, 2026 📩 www.eano.eu #election #braintumor

🙌 Shine a light on outstanding contributions! #EANO2026 Awards & Scholarships are now open for nominations: ▫️ #Research ▫️ #YoungResearchers ▫️ #Nurses & #AHP ▫️ #Diversity & #Inclusion ▫️ #Leadership 🗓️ Deadline: May 15, 2026 👉 Submit nominations: awards@eano.eu More: www.eano.eu/eanomeetings...

📚 Insights into #immunotherapy – recently published in Neuro-Oncology: Pembrolizumab monotherapy for microsatellite instability-high or mismatch repair deficient recurrent gliomas: results from the multicohort KEYNOTE-158 study 👉 doi.org/10.1007/s110... #EANOessentials #NeuroOncology #Pembrolizumab

🗳️ 𝗘𝗔𝗡𝗢 𝗘𝗹𝗲𝗰𝘁𝗶𝗼𝗻𝘀 𝟮𝟬𝟮𝟲–𝟮𝟬𝟮𝟴 𝗮𝗿𝗲 𝗼𝗽𝗲𝗻! Shape the future of neuro-oncology by joining the #EANO Executive Board or one of our committees. We invite motivated EANO members to apply and actively contribute to our community. 🗓 Deadline: May 28, 2026 💻 Learn more: www.eano.eu #EANOElections #NeuroOncology

🧪 𝗡𝗼𝘄 𝗼𝗽𝗲𝗻: #𝗘𝗔𝗡𝗢 𝗘𝗹𝗲𝗰𝘁𝗶𝗼𝗻𝘀 Be part of the Scientific Committee and help drive innovation and collaboration in the field. Submit your application by May 28, 2026 and get involved. Learn more 👉 www.eano.eu #NeuroOncology #braintumor #btsm

🚨Today, April 9, 2026, at 23:59 CEST is the very last day to submit your abstract for #EANO2026. We’re very excited to see so many submissions & are looking forward to your presentations! 👉 www.eano.eu/eano2026/abs... #Neurosurgery #NeuroOncology #RadiationOncology #AHP #nurses

🧠 Thank you for joining our #EANO Youngsters Journal Club! A great discussion on INDIGO 2.0: the next episode and an inspiring exchange across the neuro-oncology community. 👏 Many thanks to our presenter, discussants and chair for their valuable insights – and to all participants for being part!

💡 Recently published in "Cell Reports Medicine": TET CpG sequence-context-specific DNA demethylation shapes progression of IDH-mutant gliomas Open Access. Read more 🔗 t1p.de/wrciu @cellpress.bsky.social @angelodipa.bsky.social #EANOessentials #NeuroOncology #Oligodendrogliomas #OpenAccess